Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
What will Lodoco cost? Looking ahead after FDA’s colchicine approval | A new catheter recall | Cyberattack leads to lawsuit
Wednesday, June 28, 2023
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

What will Lodoco cost? Looking ahead after FDA’s historic approval of colchicine for CVD

“Our pricing strategy for Lodoco is focused on helping to ensure access to as many people as possible,” an executive with Agepha Pharma told Cardiovascular Business. 

READ MORE >
Colchicine Lodoco Agepha Pharma price cost cardiovascular disease CVD
Share on Twitter Share on Facebook Share on Linkedin

What will Lodoco cost? Looking ahead after FDA’s historic approval of colchicine for CVD

Share on Twitter Share on Facebook Share on Linkedin
Colchicine Lodoco Agepha Pharma price cost cardiovascular disease CVD
“Our pricing strategy for Lodoco is focused on helping to ensure access to as many people as possible,” an executive with Agepha Pharma told Cardiovascular Business. 
READ MORE >

FDA announces recall of more than 250,000 interventional devices due to risk of catheter separation

The FDA has said this is a Class I recall, which means using the devices “may cause serious injuries or death.” A total of 18 injuries have been reported so far. 

READ MORE >
Recall | Product recall
Share on Twitter Share on Facebook Share on Linkedin

FDA announces recall of more than 250,000 interventional devices due to risk of catheter separation

Share on Twitter Share on Facebook Share on Linkedin
Recall | Product recall
The FDA has said this is a Class I recall, which means using the devices “may cause serious injuries or death.” A total of 18 injuries have been reported so far. 
READ MORE >

Cardiology group faces class-action lawsuit after cyberattack exposed patients’ personal data

Patients learned that their names, social security numbers, banking numbers and credit card information were all potentially exposed as a result of the attack.

READ MORE >
A gavel and a stethoscope
Share on Twitter Share on Facebook Share on Linkedin

Cardiology group faces class-action lawsuit after cyberattack exposed patients’ personal data

Share on Twitter Share on Facebook Share on Linkedin
A gavel and a stethoscope
Patients learned that their names, social security numbers, banking numbers and credit card information were all potentially exposed as a result of the attack.
READ MORE >

Featured Articles

Virtual reality during TAVR: Distracting patients linked to key benefits

When patients wear VR glasses during transcatheter aortic valve replacement, they say it helps time go by more quickly and reduces anxiety.

READ MORE >
elderly patient using virtual reality TAVR transcatheter aortic valve replacement
Share on Twitter Share on Facebook Share on Linkedin

Virtual reality during TAVR: Distracting patients linked to key benefits

Share on Twitter Share on Facebook Share on Linkedin
elderly patient using virtual reality TAVR transcatheter aortic valve replacement
When patients wear VR glasses during transcatheter aortic valve replacement, they say it helps time go by more quickly and reduces anxiety.
READ MORE >

Cardiologists applaud FDA’s approval of colchicine for CVD

"The FDA's approval of colchicine confirms that we are entering a new era of patient care," said one veteran cardiologist familiar with the drug. 

READ MORE >
The U.S. Food and Drug Administration (FDA) priority review, the FDA has cleared the Agepha Pharma USA LLC's drug Lodoco (colchicine) as the first anti-inflammatory atheroprotective cardiovascular treatment. Colchicine prevents coronary artery plaque inflammation, heart inflammation. Colchicine for coronary artery disease. Colchicine for coronary inflammation FDA Approves Colchicine for Decreasing CV Events FDA Approves Colchicine for decreasing inflammation caused by coronary atherosclerosis.
Share on Twitter Share on Facebook Share on Linkedin

Cardiologists applaud FDA’s approval of colchicine for CVD

Share on Twitter Share on Facebook Share on Linkedin
The U.S. Food and Drug Administration (FDA) priority review, the FDA has cleared the Agepha Pharma USA LLC's drug Lodoco (colchicine) as the first anti-inflammatory atheroprotective cardiovascular treatment. Colchicine prevents coronary artery plaque inflammation, heart inflammation. Colchicine for coronary artery disease. Colchicine for coronary inflammation FDA Approves Colchicine for Decreasing CV Events FDA Approves Colchicine for decreasing inflammation caused by coronary atherosclerosis.
"The FDA's approval of colchicine confirms that we are entering a new era of patient care," said one veteran cardiologist familiar with the drug. 
READ MORE >

Abbott awards $2.6M to American Diabetes Association for CGM research

The three-year grant will help the ADA fund two pilot programs and engage with healthcare professionals and other industry leaders.

READ MORE >
Money dollar investments
Share on Twitter Share on Facebook Share on Linkedin

Abbott awards $2.6M to American Diabetes Association for CGM research

Share on Twitter Share on Facebook Share on Linkedin
Money dollar investments
The three-year grant will help the ADA fund two pilot programs and engage with healthcare professionals and other industry leaders.
READ MORE >

In Case You Missed It

Cardiologist agrees to pay $5M for overstating heart findings to justify unnecessary procedures

The North Carolina physician allegedly performed unnecessary atherectomy procedures to treat minor blockages in the leg arteries of multiple patients.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Cardiologist agrees to pay $5M for overstating heart findings to justify unnecessary procedures

Share on Twitter Share on Facebook Share on Linkedin
The North Carolina physician allegedly performed unnecessary atherectomy procedures to treat minor blockages in the leg arteries of multiple patients.
READ MORE >

Mitral valve repair: How a minimally invasive approach compares to conventional surgery

Researchers compared minithoracotomy, a minimally invasive procedure for treating degenerative mitral regurgitation, with conventional surgery, sharing their findings in JAMA. The research was previously presented as a late-breaking study at ACC.23. 

READ MORE >
surgery.jpg
Share on Twitter Share on Facebook Share on Linkedin

Mitral valve repair: How a minimally invasive approach compares to conventional surgery

Share on Twitter Share on Facebook Share on Linkedin
surgery.jpg
Researchers compared minithoracotomy, a minimally invasive procedure for treating degenerative mitral regurgitation, with conventional surgery, sharing their findings in JAMA. The research was previously presented as a late-breaking study at ACC.23. 
READ MORE >

In Other News

Obesity linked to altered brain connectivity on PET/MRI exams

New research, presented at SNMMI 2023, details how the brains of obese individuals differ from those who maintain a healthy weight.  

READ MORE >
molecular imaging study on brain connections in obese individuals
Share on Twitter Share on Facebook Share on Linkedin

Obesity linked to altered brain connectivity on PET/MRI exams

Share on Twitter Share on Facebook Share on Linkedin
molecular imaging study on brain connections in obese individuals
New research, presented at SNMMI 2023, details how the brains of obese individuals differ from those who maintain a healthy weight.  
READ MORE >

FDA approves Bayer’s imaging agent Ultravist for use in contrast-enhanced mammography

The Germany-based corporation said this is the “only contrast agent approved for this indication” in America. 

READ MORE >
breast cancer mammography mammogram
Share on Twitter Share on Facebook Share on Linkedin

FDA approves Bayer’s imaging agent Ultravist for use in contrast-enhanced mammography

Share on Twitter Share on Facebook Share on Linkedin
breast cancer mammography mammogram
The Germany-based corporation said this is the “only contrast agent approved for this indication” in America. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Medtech giant makes big move | The world’s top hospitals for heart surgery | New CPT codes | PET vs. SPECT | TAVR tech recalled
AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme
Trimed Popup